Extending treatment after liver transplant may benefit patients with hepatitis C recurrence

(Henry Ford Health System) Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study. “We found that patients who achieved a sustained virological response were more likely to have had extended treatment,” says Kimberly Brown, M.D., Division head of Gastroenterology at Henry Ford Hospital and senior author of the study.

source : www.eurekalert.org

Related News:

• EXPOSED: "Scandalous Abuse" of the Elderly Being Killed With Psychiatric Medications
• Big Pharma executive murders 8-year-old son with Xanax and Ambien (opinion)
• CREON(R) (pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption In Children With Cystic Fibrosis
• Older Women with Gout at Risk of MI (CME/CE)
• Designing Easy-To-Use Products With The Help Of Arthritis Simulation Gloves
• Safer Hip, Knee And Dental Implants With Smart Coating
• Sutures Cause Fewer Complications Than Staples With Cesarean Deliveries
• Heal yourself in 15 days with the Health Ranger’s living juice recipe (part five)
• SMFM: Gene Variants Linked to Preterm Labor (CME/CE, with video)
• Brain Dopamine Receptor Density Correlates With Social Status

Details :
Submited at Saturday, October 31st, 2009 at 12:00 pm on Infectious Disease by jessica
Comment RSS 2.0 - leave a comment - trackback